Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Sell
38
EYEN Quote, Financials, Valuation and Earnings
Last price:
$0.09
Seasonality move
:
13.49%
Day range:
$0.09 - $0.10
52-week range:
$0.08 - $2.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
161.08x
P/B ratio:
2.19x
Volume:
8.7M
Avg. volume:
18.4M
1-year change:
-95.47%
Market cap:
$8.1M
Revenue:
$3.8K
EPS (TTM):
-$0.71
Analysts' Opinion
-
Consensus RatingEyenovia has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Eyenovia has an estimated upside of 3615.5% from its current price of $0.09.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.09.
Fair Value
-
According to the consensus of 0 analysts, Eyenovia has 3615.5% upside to fair value with a price target of -- per share.
EYEN vs. S&P 500
-
Over the past 5 trading days, Eyenovia has overperformed the S&P 500 by 3.97% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Eyenovia does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Eyenovia has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Eyenovia reported revenues of $1.6K.
Earnings Growth
-
Eyenovia has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Eyenovia reported earnings per share of -$0.11.
Enterprise value:
12.5M
EV / Invested capital:
0.82x
Price / LTM sales:
161.08x
EV / EBIT:
--
EV / Revenue:
393.48x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-0.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$586.4K
Return On Assets:
-143.72%
Net Income Margin (TTM):
-118845.16%
Return On Equity:
-676.86%
Return On Invested Capital:
-195.21%
Operating Margin:
-451195.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | $31.8K | $1.2K | $1.6K | |
| Gross Profit | -- | -$12.2K | -$586.4K | -$12.2K | -$130.9K | |
| Operating Income | -$18.5M | -$23.3M | -$36.6M | -$6.5M | -$7.3M | |
| EBITDA | -$17.9M | -$22.2M | -$34.1M | -$6.3M | -$7M | |
| Diluted EPS | -$0.57 | -$0.66 | -$0.71 | -$0.18 | -$0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.4M | $23.5M | $29.4M | $26.5M | $11.7M | |
| Total Assets | $25.8M | $25M | $31.4M | $34.9M | $22.8M | |
| Current Liabilities | $6.7M | $20.7M | $11M | $6.5M | $15.8M | |
| Total Liabilities | $7.2M | $20.7M | $11.1M | $19.1M | $19.1M | |
| Total Equity | $18.7M | $4.2M | $20.3M | $15.8M | $3.7M | |
| Total Debt | -- | $7.3M | $7.2M | $14.1M | $11.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$25.6M | -$22.9M | -$30.3M | -$5.8M | -$5.9M | |
| Cash From Investing | -$1M | -$4.1M | -$306.7K | -$1.7M | -$1.6K | |
| Cash From Financing | $30.5M | $22.5M | $17.1M | $10.8M | $10.8M | |
| Free Cash Flow | -$26.6M | -$27.1M | -$30.6M | -$7.5M | -$5.9M | |
EYEN
Sector
Market Cap
$8.1M
$46.5M
Price % of 52-Week High
3.67%
47.23%
Dividend Yield
0%
0%
Shareholder Yield
-50.37%
-0.6%
1-Year Price Total Return
-95.47%
-31.38%
Beta (5-Year)
1.434
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.09
200-day SMA
Sell
Level
$0.65
Bollinger Bands (100)
Sell
Level
0.18 - 0.66
Chaikin Money Flow
Sell
Level
-102.7M
20-day SMA
Sell
Level
$0.09
Relative Strength Index (RSI14)
Sell
Level
33.67
ADX Line
Buy
Level
17.13
Williams %R
Neutral
Level
-67.1128
50-day SMA
Sell
Level
$0.27
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
101.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.5913)
Sell
CA Score
(Annual)
Level (-4.4995)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (7.3504)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Stock Forecast FAQ
In the current month, EYEN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EYEN average analyst price target in the past 3 months is --.
-
Where Will Eyenovia Stock Be In 1 Year?
According to analysts, the consensus estimate is that Eyenovia share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Eyenovia?
Analysts are divided on their view about Eyenovia share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Eyenovia is a Sell and believe this share price will drop from its current level to --.
-
What Is Eyenovia's Price Target?
The price target for Eyenovia over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EYEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Eyenovia is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of EYEN?
You can purchase shares of Eyenovia via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Eyenovia shares.
-
What Is The Eyenovia Share Price Today?
Eyenovia was last trading at $0.09 per share. This represents the most recent stock quote for Eyenovia. Yesterday, Eyenovia closed at $0.09 per share.
-
How To Buy Eyenovia Stock Online?
In order to purchase Eyenovia stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
